Literature DB >> 20509747

Carbonic anhydrases II and XII are up-regulated in osteoclast-like cells in advanced human atherosclerotic plaques-Tampere Vascular Study.

Niku Oksala1, Mari Levula, Markku Pelto-Huikko, Leena Kytömäki, Juhani T Soini, Juha Salenius, Mika Kähönen, Pekka J Karhunen, Reijo Laaksonen, Seppo Parkkila, Terho Lehtimäki.   

Abstract

BACKGROUND AND AIMS: Carbonic anhydrases (CA) play a central role in osteoclast function and bone remodeling by catalyzing the formation of bicarbonate and proton from carbon dioxide. According to previous histochemical studies, advanced atherosclerotic plaques share similarities with bone. However, whether CAs are expressed in plaques is not known. METHODS AND
RESULTS: Whole genome expression array of arterial samples (n = 24) confirmed that several genes indicating osteoblastogenesis and osteoclastogenesis were up-regulated in plaques when compared to control vessel samples from internal thoracic arteries (n = 6), including CA2 and CA12, expression of which was also verified with quantitative reverse transcription polymerase chain reaction (RT-PCR). In atherosclerotic plaques there was 11.6-fold (P < 0.0001) and 11.4-fold (P < 0.0001) up-regulation of CA2 and CA12, compared to controls, respectively. According to quantitative PCR, CA2 expression was elevated in carotid (12.3-fold, P < 0.0001), femoral (13.2-fold, P < 0.01), and aortic plaques (7.5-fold, P < 0.0001). CA12 expression was elevated in carotid (11.6-fold, P < 0.0001), femoral (11.5-fold, P < 0.01), and aortic plaques (9.7-fold, P < 0.0001). CAII, CAXII, and CD68 and tartrate-resistant acid phosphatase (TRAP), a marker of osteoclast-like cells, were found to be co-localized in multinucleated giant cells in the atherosclerotic plaques using immunohistochemistry and double-staining immunofluorescence analysis.
CONCLUSIONS: The present findings provide evidence for the involvement of CAs in advanced atherosclerosis in osteoclast-like cells of monocyte-macrophage lineage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20509747     DOI: 10.3109/07853890.2010.486408

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  12 in total

Review 1.  Carbonic anhydrase XII inhibition overcomes P-glycoprotein-mediated drug resistance: a potential new combination therapy in cancer.

Authors:  Kathryn F Tonissen; Sally-Ann Poulsen
Journal:  Cancer Drug Resist       Date:  2021-06-19

Review 2.  Vascular calcification: an update on mechanisms and challenges in treatment.

Authors:  Meiting Wu; Cameron Rementer; Cecilia M Giachelli
Journal:  Calcif Tissue Int       Date:  2013-03-01       Impact factor: 4.333

Review 3.  Clinical Application of Endothelial Progenitor Cell: Are We Ready?

Authors:  Chao-Hung Wang; Po-Hsun Huang; Jaw-Wen Chen; Shing-Jong Lin; Ming-Feng Lee; Ning-I Yang; Wen-Jin Cherng
Journal:  Acta Cardiol Sin       Date:  2013-11       Impact factor: 2.672

4.  Osteoprotegerin, pericytes and bone-like vascular calcification are associated with carotid plaque stability.

Authors:  Jean-Michel Davaine; Thibaut Quillard; Régis Brion; Olivier Lapérine; Béatrice Guyomarch; Thierry Merlini; Mathias Chatelais; Florian Guilbaud; Meadhbh Áine Brennan; Céline Charrier; Dominique Heymann; Yann Gouëffic; Marie-Françoise Heymann
Journal:  PLoS One       Date:  2014-09-26       Impact factor: 3.240

5.  Differentially expressed genes and canonical pathway expression in human atherosclerotic plaques - Tampere Vascular Study.

Authors:  Miska Sulkava; Emma Raitoharju; Mari Levula; Ilkka Seppälä; Leo-Pekka Lyytikäinen; Ari Mennander; Otso Järvinen; Rainer Zeitlin; Juha-Pekka Salenius; Thomas Illig; Norman Klopp; Nina Mononen; Reijo Laaksonen; Mika Kähönen; Niku Oksala; Terho Lehtimäki
Journal:  Sci Rep       Date:  2017-01-27       Impact factor: 4.379

6.  The effects of cardiac drugs on human erythrocyte carbonic anhydrase I and II isozymes.

Authors:  Onur Argan; Kübra Çıkrıkçı; Aybike Baltacı; Nahit Gencer
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

7.  Upstream Transcription Factor 1 (USF1) allelic variants regulate lipoprotein metabolism in women and USF1 expression in atherosclerotic plaque.

Authors:  Yue-Mei Fan; Jussi Hernesniemi; Niku Oksala; Mari Levula; Emma Raitoharju; Auni Collings; Nina Hutri-Kähönen; Markus Juonala; Jukka Marniemi; Leo-Pekka Lyytikäinen; Ilkka Seppälä; Ari Mennander; Matti Tarkka; Antti J Kangas; Pasi Soininen; Juha Pekka Salenius; Norman Klopp; Thomas Illig; Tomi Laitinen; Mika Ala-Korpela; Reijo Laaksonen; Jorma Viikari; Mika Kähönen; Olli T Raitakari; Terho Lehtimäki
Journal:  Sci Rep       Date:  2014-04-11       Impact factor: 4.379

Review 8.  Should EMT of Cancer Cells Be Understood as Epithelial-Myeloid Transition?

Authors:  Henning M Schramm
Journal:  J Cancer       Date:  2014-01-15       Impact factor: 4.207

9.  A novel MMP12 locus is associated with large artery atherosclerotic stroke using a genome-wide age-at-onset informed approach.

Authors:  Matthew Traylor; Kari-Matti Mäkelä; Laura L Kilarski; Elizabeth G Holliday; William J Devan; Mike A Nalls; Kerri L Wiggins; Wei Zhao; Yu-Ching Cheng; Sefanja Achterberg; Rainer Malik; Cathie Sudlow; Steve Bevan; Emma Raitoharju; Niku Oksala; Vincent Thijs; Robin Lemmens; Arne Lindgren; Agnieszka Slowik; Jane M Maguire; Matthew Walters; Ale Algra; Pankaj Sharma; John R Attia; Giorgio B Boncoraglio; Peter M Rothwell; Paul I W de Bakker; Joshua C Bis; Danish Saleheen; Steven J Kittner; Braxton D Mitchell; Jonathan Rosand; James F Meschia; Christopher Levi; Martin Dichgans; Terho Lehtimäki; Cathryn M Lewis; Hugh S Markus
Journal:  PLoS Genet       Date:  2014-07-31       Impact factor: 5.917

10.  Bovine parathyroid hormone enhances osteoclast bone resorption by modulating V-ATPase through PTH1R.

Authors:  Shuangxin Liu; Weiping Zhu; Sijia Li; Jianchao Ma; Huitao Zhang; Zhonghe Li; Li Zhang; Bin Zhang; Zhuo Li; Xinling Liang; Wei Shi
Journal:  Int J Mol Med       Date:  2015-12-07       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.